
API Trade: Licensed importation & supply of Active Pharmaceutical Ingredients

SAHPRA Licensed. Globally Connected.
In September 2025, Alura Pharmaceuticals obtained its SAHPRA Section 22 licence to import and distribute scheduled substances, including Active Pharmaceutical Ingredients (APIs).
This enables our team to support South African manufacturers, compounding pharmacies and veterinary businesses with the compliant sourcing, importation and supply of scheduled substances.
Through our growing international supplier network and local pharmaceutical expertise, we can assist with both bulk API requirements and specialised niche quantities.
What are APIs?
An Active Pharmaceutical Ingredient (API), also referred to as an Active Ingredient (AI), is the biologically active component of a pharmaceutical product responsible for its intended therapeutic effect.
Our approach
Compliance First
Operating within applicable SAHPRA, SAPC and Department of Health requirements and Good Distribution Practice guidelines.
International Sourcing
Access to an international network of pharmaceutical suppliers, pharmacists, scientists and procurement specialists.
Built Around Your Requirements
Support for both bulk API requirements and specialised quantities for niche applications.
Clear, Responsive Service
Transparent communication, practical support and a focus on efficient, cost-conscious sourcing.
Meet Pieter, our API Trader

Pieter Herman, former Managing Director of Alura Pharmaceuticals, brings extensive industry knowledge and a strong international network to the API division. Through CPHI Milan 2024 and Frankfurt 2025, he established valuable relationships with global suppliers of APIs, excipients and minerals.
Pieter now focuses on developing Alura's API business and sourcing scheduled substances for the South African market.
Contact
Unit 15, Lower Ground Level, SAPPI Technology Centre, Cnr Aaron Klug and Max Theiler Streets, Innovation Hub, Persequor, Pretoria, 0022.